JenaValve

Company Snapshot

Founded: 2006
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S., Germany, U.K.
Corporate Address: 4 Cromwell, Irvine, California 92618, U.S. Tel.: +1-949-767-2110 Web.: www.jenavalve.com

Company Overview

JenaValve Technology, established in 2006, develops transcatheter aortic valve replacement (TAVR) systems. It first-generation transapical system, consisting of the JenaValve valve with Cathlete Plus delivery system, was commercialized under CE Mark approval for aortic valve stenosis and for aortic valve regurgitation. The new JenaValve Pericardial TAVR System consists of the Everdur pericardial aortic valve (manufactured at JenaValve’s U.K. facility) and the transfemoral delivery system. The bioprosthesis comprises a self-expanding nitinol stent with a porcine pericardial valve manufactured using state-of-the-art tissue processing techniques. The Coronatix transfemoral delivery catheter is designed to deliver the bioprosthesis using a simple stepped approach with anatomic positioning over the native valve. The system is available in three sizes intended for aortic annulus diameters from 21 mm to 27 mm. A larger bioprosthesis size is in development.

JenaValve In Reports

Global Markets for Emerging Medical Device Technologies

BCC Research Market Report says emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at a (CAGR) of 12.3%.

Transcatheter Treatment: Procedures and Heart Valve Market

BCC Market Research Report says transcatheter treatment devices should grow from $7.1 billion in 2020 to $15.2 billion by 2025, at compound annual growth rate of 16.3%.

Transcatheter Treatment: Procedures and Heart Valve Market

The global market for transcatheter treatment devices should grow from $4.0 billion in 2018 to $8.0 billion by 2023 at a compound annual growth rate (CAGR) of 14.8% for the period of 2018-2023. ...

Company's Business Segments

  • Product : Trilogy THV System, Aortic Regurgitation Trial Investigating Surgery (ARTIST) Trial, Others
  • Service : Clinical Development, Partnerships and Training, Integrity and Compliance, Others

Applications/End User Industries

  • Healthcare
  • Hospitals and Clinics
  • Life Sciences
  • Cardiac Surgery
  • Cardiology
AI Sentiment